Vaccine makers push for boosters — CBO on drug development — USTR will weigh case-by-case tariff exclusions
From: POLITICO's Prescription Pulse - Friday Aug 27,2021 04:02 pm
|
More emails from POLITICO's Prescription Pulse
Aug 24,2021 04:02 pm - Tuesday
First Covid-19 vaccine approval — PDUFA VII commitments — antitrust trial over cancer testAug 20,2021 04:02 pm - Friday
White House prepares booster rollout ahead of regulatory thumbs-up — Pharmacies gird for third dose onslaught — Illumina buys Grail despite antitrust heatAug 13,2021 04:03 pm - Friday
CDC advisers set to sanction third Covid shots for immunocompromised — Biden touts plan to cut Medicare drug costs — Medical device industry outlines user fee asksAug 10,2021 04:02 pm - Tuesday
The debate over vaccinating kids against Covid — CDC advisers expected to make additional dose recommendations — Another name in the mix for FDA chiefAug 06,2021 04:04 pm - Friday
Moderna touts vaccine protection, plans boosters — Novavax again delays vaccine EUA submission — HHS IG scrutinizing accelerated approval pathway